ImmuPharma PLC announced that Dr. Franco Di Muzio, senior Non-Executive Director will take on the role of Chairman on an interim basis. Due to recent ill health, Richard Warr, Executive Chairman, has taken a leave of absence in order to make a full recovery.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.17 GBX | +4.33% |
|
+0.23% | +30.17% |
06-05 | EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows | AN |
06-05 | ImmuPharma plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.17% | 10.95M | |
+16.64% | 45.51B | |
-9.89% | 38.52B | |
+38.08% | 38.13B | |
+27.10% | 30.74B | |
-8.64% | 26.03B | |
+11.68% | 25.92B | |
+45.52% | 14.13B | |
+33.69% | 12.73B | |
-7.71% | 11.29B |
- Stock Market
- Equities
- IMM Stock
- News ImmuPharma plc
- ImmuPharma Plc Announces Management Changes